CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Instituto de Biociências (IB) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Professor at the Department of Genetics and Evolutionary Biology at the Institute of Biosciences at the University of São Paulo. Expert in advanced therapies, focusing on stem cells and tissue engineering. PhD in Genetics from the University of São Paulo. Master's degree in Biological Sciences: Genetics and Biotechnology from the Federal University of Juiz de Fora. Graduated in Pharmacy from the Federal University of Juiz de Fora. Awarded member of the ISSCR. He served as a guest researcher at the Department of Bioengineering at Temple University - Philadelphia, at the TIME research center - Temple Institute for Regenerative Medicine and Engineering under the guidance of Dr. Peter I. Lelkes. He completed his doctorate under the guidance of Dr. Mayana Zatz. Works in the area of Genetics, Cellular and Molecular Biology and Physiology. He is currently a researcher at the Human Genome and Stem Cell Studies Center - USP and works in the area of tissue bioengineering/biomaterials, with a focus on liver tissue engineering (3D bioprinting and liver organoids) and genetic engineering, with a focus on xenotransplantation. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Organ and/or tissue failure is responsible for 45% of annual deaths in the world. Tissue engineering is an attractive solution, because it allows the development of functional tissues for partial or total transplants or implants. Artificial tissues require functional cells, and primary cells are the gold standard for functionality, but they are not suitable for long in vitro cultivation.…
Induced pluripotent stem cells (iPSCs) are reprogrammed cell lines derived in vitro from fibroblasts or erythroblasts which, similar to embryonic stem cells (ESCs), can differentiate into all tissues of an organism. Due to their high proliferative potential and permissiveness to gene editing and clonal selection, iPSCs are highly applicable for cellular therapies in humans. Immunological …
Induced pluripotent stem cells (iPSCs) are in vitro reprogrammed cell lines derived from fibroblasts or erythroblasts that, like embryonic stem cells (ESCs), have the ability to differentiate into all tissues of an organism. Due to their high proliferative potential and permissiveness to gene editing and clonal selection, iPSCs have great potential for cellular therapies in humans. Immuno…
Hepatic organoid technology holds great promise for the development of future Regenerative Medicine strategies to treat patients with severe liver disease. Recently, some studies have demonstrated robust protocols for isogenic organoid generation using induced Pluripotent Stem cells (iPS). However, using patient's specific iPS-derived cells poses a major challenge for a translational pers…
The liver is a key organ in the regulation of metabolism and hemodynamics. Several acute and chronic liver diseases (i.e. resulting from toxic exposures or congenital diseases) progress for a severe loss of hepatic function. Currently, the only therapeutic option for patients with end-stage and/or progressively severe liver disease is the partial or total organ transplant. Due to the shor…
| 2 / 2 | Ongoing scholarships in Brazil |
| 3 / 3 | Completed scholarships in Brazil |
| 5 / 5 | All Scholarships |
| Associated processes | |